Richard Brotherton

Statistics

Publications

Citations

137

H-Index

Active since

2017

Affiliations

Stanford University(Current)

Richard Brotherton is an author at Stanford University specializing in molecular oncology, targeted therapy, and advanced basal cell carcinoma therapy.

Publications per year

2017–2018

Publications

Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study

Anne Lynn S. Chang, Duy Tran, John G. D. Cannon et al. · Journal of the American Academy of Dermatology · 2018 · 116 citations · Full text

Medicine, Dermatology, Oncology +17

An exploratory open-label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas

Duy Tran, A. D. Moffat, Richard Brotherton et al. · Journal of the American Academy of Dermatology · 2017 · 21 citations

Medicine, Oncology, Pharmacology +11

1–2 of 2